label - accessdata.fda.gov
These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.
Tryngolza: Package Insert / Prescribing Information / MOA
Feb 9, 2025 · Tryngolza package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Support Resources | TRYNGOLZA® (olezarsen) Injection
Access downloadable resources and watch videos to support your TRYNGOLZA® treatment journey. See Safety & Full Prescribing Information.
FDA Label for Tryngolza Injection, Solution Subcutaneous - Indications ...
Table of Contents Tryngolza Product Label The following document was submitted to the FDA by the labeler of this product Ionis Pharmaceuticals, Inc.. The document includes published materials …
TRYNGOLZA - info.caremark.com
Specialty Guideline Management Tryngolza Products Referenced by this Document Drugs that are listed in the following table include both brand and generic and all dosage forms and strengths unless …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.
PRODUCT FACT SHEET - ionis.com
The most common side effects of TRYNGOLZA include injection site reactions, decreased platelet count and arthralgia.1 TRYNGOLZA is self-administered via an auto-injector monthly.1 rmation on page 2. …
Tryngolza | European Medicines Agency (EMA)
Jul 25, 2025 · Tryngolza can only be obtained with a prescription and is available as a solution for injection in prefilled pens. It is injected once a month under the skin in the abdomen (belly), the front …
label - accessdata.fda.gov
Medication Guide TEVIMBRA (teh-vim-brah) (tislelizumab-jsgr) injection What is the most important information I should know about TEVIMBRA? TEVIMBRA is a medicine that may treat certain cancers …
Tislelizumab
WHAT IS TISLELIZUMAB? Tislelizumab is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high afinity and binding …